Study guide

5.2 Acute Coronary Syndromes, Heart Failure & Shock Classifications

Nursing and Midwifery Council of Ghana Licensing Examinations Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: N&MC Ghana Regulation, Licensing Pathway & Examination Format

1.1 Health Professions Regulatory Bodies Act, 2013 (Act 857) & the N&MC Mandate 1.2 Cadres, Indexing, Eligibility, Examination Windows & Fees 1.3 Registration, PIN vs. AIN, Rotation, Licence Renewal & Foreign-Trained Pathway 1.4 Examination Format: Computer-Based Papers, Practical Component, Results & Re-sits

2 Chapter 2: Professional Ethics, Law, Leadership & Patient Rights

2.1 N&MC Ghana Code of Conduct, Ethical Principles & Professional Boundaries 2.2 Ghana Health Service Patients' Charter, Informed Consent & Confidentiality 2.3 Clinical Documentation, Incident Reporting, Negligence & Legal Liability 2.4 Nursing Leadership, Ward Management, Handover & Team Communication

3 Chapter 3: Infection Prevention, Control & Healthcare Safety

3.1 Standard & Transmission-Based Precautions, Hand Hygiene & PPE 3.2 Sterilization, Decontamination & Healthcare Waste Management in Ghana 3.3 Injection Safety, Sharps Injury Prevention & Occupational Post-Exposure Prophylaxis

4 Chapter 4: Clinical Nursing Foundations, Nursing Process & Practical Skills

4.1 Vital Signs Assessment, Clinical Deterioration & Early Warning Scoring 4.2 Medication Administration, Dosages, High-Alert Drugs & Pharmacovigilance 4.3 Enteral & Parenteral Nutrition, Fluid and Electrolyte Balance & Acid-Base Disorders 4.4 Pain Assessment, Analgesic Ladder & Palliative Care in Ghana 4.5 Nursing Process, Care Plans, Care Study & the Practical Examination

5 Chapter 5: Respiratory, Cardiovascular & Neurological Nursing

5.1 Airway, Breathing & Oxygen Therapy: Asthma, COPD & Pneumonia 5.2 Acute Coronary Syndromes, Heart Failure & Shock Classifications 5.3 Hypertension Management, Hypertensive Emergencies & Stroke Care 5.4 Neurological Nursing: Unconscious Patient, Head Injury, Raised ICP & Epilepsy

6 Chapter 6: Endocrine, Renal, Gastrointestinal & Liver Disorders

6.1 Diabetes Mellitus, DKA, HHS & Glycemic Emergencies 6.2 Acute Kidney Injury, Chronic Kidney Disease & Fluid Overload 6.3 Acute Abdomen, Peptic Ulcer Disease & Gastrointestinal Bleeding 6.4 Liver Disease (Hepatitis B, Cirrhosis, Hepatic Encephalopathy) & Thyroid Disorders

7 Chapter 7: Endemic Tropical Infections & Communicable Diseases

7.1 Malaria Management: Diagnostics, Uncomplicated & Severe Malaria Protocols 7.2 Tuberculosis Diagnosis, DOTS Protocol & Infection Control 7.3 HIV/AIDS Management, Antiretroviral Therapy (ART) & Opportunistic Infections 7.4 Enteric Infections: Cholera, Typhoid Fever & Diarrhoea Outbreak Response

8 Chapter 8: Hematology & Common Non-Communicable Conditions

8.1 Sickle Cell Disease: Vaso-Occlusive Crises, Anemia & Organ Protection 8.2 Blood Transfusion Practice, Crossmatching & Transfusion Reactions 8.3 Venous Thromboembolism, Anticoagulation & Pressure Injury Prevention

9 Chapter 9: Perioperative, Urological & Gynaecological Surgical Nursing

9.1 Preoperative Evaluation, Patient Preparation & Informed Consent 9.2 Intraoperative Care, Surgical Asepsis & WHO Surgical Safety Checklist 9.3 Postoperative Complications, Wound Healing & Dressing Techniques 9.4 Anesthesia Overview, Recovery Room (PACU) Care & Pain Management 9.5 Urological Surgical Nursing: Retention, BPH, Prostatectomy, Calculi & Catheter Care 9.6 Gynaecological Nursing: Ectopic Pregnancy, Abortion Care, Fibroids, PID & Cancer Screening

10 Chapter 10: Trauma, Burns & Acute Emergency Management

10.1 ABCDE Primary/Secondary Survey & Disaster Triage (START) 10.2 Major Burns: Rule of Nines, Parkland Fluid Resuscitation & Wound Care 10.3 Fractures, Immobilization, Compartment Syndrome & Spinal Precautions 10.4 Environmental Emergencies: Snakebites, Poisoning & Tetanus Prophylaxis

11 Chapter 11: Maternal Health, Obstetric & Postnatal Nursing

11.1 Antenatal Care (ANC/FANC), Risk Assessment & Health Promotion 11.2 Normal Labor, Stages & Partograph Monitoring 11.3 Obstetric Complications: Postpartum Hemorrhage (PPH) & Active Third Stage (AMTSL) 11.4 Hypertensive Disorders of Pregnancy: Preeclampsia, Eclampsia & MgSO4 11.5 Postnatal Care, Breastfeeding Support & Family Planning

12 Chapter 12: Neonatal & Pediatric Nursing Care

12.1 Immediate Newborn Care, APGAR Scoring & Neonatal Resuscitation 12.2 Integrated Management of Neonatal & Childhood Illness (IMNCI) 12.3 Ghana Expanded Programme on Immunization (EPI) & Pediatric Malnutrition

13 Chapter 13: Community Health Nursing & Primary Healthcare in Ghana

13.1 Community-Based Health Planning and Services (CHPS) Model 13.2 Disease Surveillance, Epidemic Preparedness & Community Health Education 13.3 Environmental Sanitation, Water Safety & School Health Services

14 Chapter 14: Mental Health Nursing & Psychiatric Care

14.1 Mental Health Act, 2012 (Act 846): Authority, Admission Routes & Rights 14.2 Common Psychiatric Disorders: Depression, Bipolar, Schizophrenia & Psychosis 14.3 Psychiatric Emergencies: Suicide Risk Assessment & De-escalation

5.2 Acute Coronary Syndromes, Heart Failure & Shock Classifications

Key Takeaways Explain This Topic AI

Acute Coronary Syndromes (ACS) span a pathophysiological spectrum from Unstable Angina to NSTEMI and STEMI, distinguished by clinical presentation, 12-lead ECG changes (hyperacute T waves, ST-elevation >= 1 mm, pathological Q waves), and cardiac troponin release kinetics.

Emergency ACS care centers on the rapid MONA protocol (Morphine, Oxygen for SpO2 < 90%, Nitroglycerin, and chewed Aspirin 300 mg) and definitive reperfusion windows: percutaneous coronary intervention (PCI) within 90 minutes or fibrinolysis within 30 minutes.

Heart failure manifests as left-sided failure (pulmonary venous congestion, dyspnea, orthopnea, paroxysmal nocturnal dyspnea, bibasilar rales) or right-sided failure (systemic venous congestion, jugular venous distention, peripheral edema, hepatomegaly, ascites).

Digoxin therapy requires strict clinical surveillance (narrow therapeutic range 0.5–2.0 ng/mL, 60-second apical pulse check holding if HR < 60 bpm); loop diuretic-induced hypokalemia is the leading trigger for digitalis toxicity manifesting as nausea, visual yellow-green halos, and fatal dysrhythmias.

Shock represents inadequate tissue perfusion categorized into hypovolemic, cardiogenic, distributive (septic, anaphylactic, neurogenic), and obstructive types; management follows progressive staging to avoid multi-organ dysfunction syndrome through targeted fluid boluses, norepinephrine, and inotropes.

Last updated: September 2026

5.2 Acute Coronary Syndromes, Heart Failure & Shock Classifications

Quick Answer: Acute Coronary Syndromes (ACS) encompass a pathophysiological continuum from unstable angina to NSTEMI and STEMI, distinguished by clinical presentation, 12-lead ECG findings, and cardiac troponin biomarker kinetics. Emergency nursing management prioritizes the rapid MONA protocol, timely reperfusion (door-to-balloon PCI within 90 minutes or fibrinolysis within 30 minutes), and continuous cardiac rhythm monitoring. Heart failure manifests with distinct hemodynamic profiles: left-sided failure causes pulmonary vascular congestion, while right-sided failure leads to systemic venous overload; both require strict daily weight monitoring, sodium restriction, and careful administration of loop diuretics, ACE inhibitors, and digoxin while monitoring for toxicity. Shock represents systemic cellular hypoperfusion categorized into hypovolemic, cardiogenic, distributive (septic, anaphylactic, neurogenic), and obstructive shock, each evolving through four progressive pathophysiological stages requiring rapid targeted fluid resuscitation, vasopressors, and inotropic support.

The Spectrum of Coronary Artery Disease and Acute Coronary Syndromes

Coronary Artery Disease (CAD) arises from progressive atherosclerotic plaque accumulation within the epicardial coronary arteries. When an unstable, lipid-rich atheromatous plaque undergoes superficial erosion, ulceration, or frank rupture, subendothelial collagen is exposed to circulating platelets. Platelet activation, adhesion, and thrombin generation precipitate acute intraluminal coronary thrombosis, creating the clinical spectrum of Acute Coronary Syndromes (ACS) . ATHEROSCLEROTIC PLAQUE RUPTURE

  • |
  • v
  • PLATELET ACTIVATION & THROMBOSIS
  • |
  • +------------------+------------------+
  • | |
  • PARTIAL OCCLUSION COMPLETE OCCLUSION
  • | |
  • +--------+--------+ v
  • | | STEMI
  • v v (Persistent ST-elevation,
  • UNSTABLE ANGINA NSTEMI transmural necrosis,
  • (No biomarkers; (Troponin elevated; positive troponin)
  • ischemia at rest) ST-depression/T-inv)

Clinical Entity Coronary Pathology 12-Lead ECG Findings Cardiac Biomarkers (Troponin) Pain Character & Relief

Stable Angina Fixed atherosclerotic stenosis (> 70%) without acute thrombus Normal baseline or transient ST-depression during exertion Negative (Troponin normal) Predictable chest pain on physical exertion or emotional stress; relieved within 5 minutes by rest or sublingual nitroglycerin.

Unstable Angina Non-occlusive, transient thrombus over ruptured plaque Normal, transient ST-depression, or T-wave inversion Negative (Troponin normal) Occurs at rest or with minimal exertion; crescendo pattern (increasing frequency, severity, or duration); unheralded onset.

NSTEMI Non-occlusive thrombus causing partial-thickness, subendocardial necrosis Persistent ST-segment depression, T-wave inversion, or non-specific Positive (Elevated Troponin I and T) Prolonged, severe retrosternal pain at rest (> 20 minutes); not fully relieved by rest or sublingual nitrates.

STEMI Complete, occlusive intraluminal thrombus causing full-thickness transmural necrosis Persistent ST-elevation (>= 1 mm in limb leads, >= 2 mm in precordial leads) or new LBBB Positive (Dramatically elevated Troponin I and T) Crushing, severe retrosternal crushing pain, diaphoresis, impending doom; refractory to nitroglycerin; requires emergent reperfusion.

Diagnostic Triad of Acute Myocardial Infarction

Definitive diagnosis of acute myocardial infarction requires at least two of the following three elements:

Clinical History: Heavy, retrosternal chest pressure, squeezing, fullness, or aching pain, frequently radiating to the left shoulder, left arm, neck, lower jaw, or epigastrium. Accompanied by profuse diaphoresis, dyspnea, nausea, vomiting, dizziness, and Levine's sign (patient holding a clenched fist over the sternum).

Atypical Presentations: Female, elderly, and diabetic patients frequently present without chest pain ("silent ischemia"), reporting isolated dyspnea, unexplained fatigue, syncope, nausea, or epigastric discomfort.

12-Lead Electrocardiogram (ECG):

  • Hyperacute T Waves: Tall, peaked, symmetrical T waves developing within minutes of arterial occlusion;
  • ST-Segment Elevation: Indicates acute transmural myocardial injury (epicardial injury current);

Pathological Q Waves: Development of Q waves >= 0.04 seconds (one small box) in duration and >= 25% of the total R-wave amplitude, signifying irreversible full-thickness myocardial necrosis.

Cardiac Biomarkers:

Cardiac Troponins (cTnI and cTnT): Highly specific, gold-standard contractile regulatory proteins. Serum levels rise within 3 to 4 hours following myocardial injury, peak at 12 to 24 hours , and remain elevated for 7 to 14 days , providing a wide diagnostic window;

Creatine Kinase-MB (CK-MB): Rises within 4 to 6 hours , peaks at 18 to 24 hours , and returns to normal baseline within 48 to 72 hours . CK-MB is clinically valuable for diagnosing early re-infarction (recurrent ischemia occurring several days after the initial event when troponin levels remain elevated from the primary insult).

  • Emergency Acute Nursing Management & Reperfusion Windows
  • The Immediate Resuscitation Protocol

Upon suspecting an acute coronary syndrome, immediate actions must be instituted without delay: +--------------------------------------------------------------------------+

  • | EMERGENCY ACS NURSING PRIORITIES |
  • +--------------------------------------------------------------------------+
  • | - Aspirin (ASA): 160 to 325 mg non-enteric coated tablet chewed |
  • | immediately (inhibits thromboxane A2). |
  • | |
  • | - Oxygen Therapy: Indicated ONLY if SpO2 < 90% or patient in |
  • | respiratory distress (hyperoxia triggers |
  • | coronary vasoconstriction and reperfusion injury)|
  • | |
  • | - Nitroglycerin (NTG): 0.4 mg sublingual tablet every 5 min (max 3 |
  • | doses). Dilates coronary arteries and veins. |
  • | |
  • | - Morphine Sulfate: 2 to 4 mg slow IV push for refractory chest pain |
  • | and pulmonary congestion; reduces preload. |
  • +--------------------------------------------------------------------------+

Caution

Critical Contraindications for Nitroglycerin: Nurses must never administer nitrates if:

Systolic blood pressure is < 90 mmHg or heart rate is < 50 bpm;

The patient has ingested a Phosphodiesterase-5 (PDE-5) inhibitor (e.g., sildenafil, vardenafil within 24 hours, or tadalafil within 48 hours), as this combination triggers catastrophic, refractory vasodilation and fatal cardiovascular collapse;

An inferior-wall STEMI with right ventricular (RV) infarction is present (leads II, III, aVF, and right-sided V4R elevation). The ischemic right ventricle is highly preload-dependent; nitrates precipitously drop preload, inducing profound cardiogenic shock.

Time-Critical Reperfusion Windows

Myocardial salvage is strictly time-dependent ("time is muscle"):

Percutaneous Coronary Intervention (PCI): The gold-standard mechanical reperfusion method (balloon angioplasty with drug-eluting stent placement). Goal: Door-to-balloon time < 90 minutes at a PCI-capable center, or < 120 minutes if requiring inter-facility transfer.

Thrombolytic / Fibrinolytic Therapy: Intravenous administration of tissue plasminogen activator (Alteplase, Tenecteplase, or Streptokinase) indicated when primary PCI cannot be delivered within 120 minutes. Goal: Door-to-needle time < 30 minutes .

Absolute Contraindications to Fibrinolysis: Prior intracranial hemorrhage, known structural cerebral vascular malformation (AVM), malignant intracranial neoplasm, ischemic stroke within 3 months, active internal bleeding, or suspected aortic dissection.

Heart Failure: Left-Sided vs. Right-Sided Heart Failure

Heart failure (HF) is a complex clinical syndrome resulting from structural or functional cardiac impairment, leading to elevated intracardiac pressures and inadequate systemic perfusion at rest or during physiological stress. LEFT-SIDED HEART FAILURE RIGHT-SIDED HEART FAILURE

  • (Left Ventricular Failure) (Cor Pulmonale / RV Failure)
  • | |
  • v v
  • Elevated LV End-Diastolic Pressure Elevated RV End-Diastolic Pressure
  • | |
  • v v
  • Backward Pressure into Pulmonary Veins Backward Pressure into Systemic Veins
  • | |
  • v v
  • PULMONARY CONGESTION & EDEMA SYSTEMIC VENOUS CONGESTION
  • Dyspnea & Orthopnea - Jugular Venous Distention (JVD)
  • Paroxysmal Nocturnal Dyspnea (PND) - Dependent Peripheral Edema
  • Bilateral Basilar Crackles (Rales) - Hepatomegaly & Ascites
  • Cough with Pink Frothy Sputum - Hepatojugular Reflux & Weight Gain
  • Clinical Comparison of Failure Manifestations

Left-Sided Heart Failure (Pulmonary Manifestations):

Dyspnea and Tachypnea: Due to pulmonary vascular congestion and fluid accumulation in alveolar spaces;

Orthopnea: Dyspnea provoked by lying supine, relieved by sitting upright; quantified by the number of pillows required to sleep;

Paroxysmal Nocturnal Dyspnea (PND): Severe, sudden shortness of breath awakening the patient from sleep 1 to 2 hours after recumbency, caused by central redistribution of dependent interstitial fluid;

Auscultation: Bibasilar inspiratory crackles (crepitations), wheezes ("cardiac asthma"), and an audible S3 ventricular gallop reflecting volume overload in a non-compliant ventricle;

Acute Pulmonary Edema: Extreme dyspnea, cyanosis, diaphoresis, air hunger, and production of copious, thin, pink, frothy sputum .

Right-Sided Heart Failure (Systemic Manifestations):

The most common cause of right-sided heart failure is pre-existing left-sided heart failure (pulmonary hypertension backward failure);

Jugular Venous Distention (JVD): Elevation of internal jugular venous pulsation > 4 cm above the sternal angle at 45 degrees inclination;

Dependent Peripheral Edema: Symmetrical, pitting edema developing in gravity-dependent areas (ankles and pretibial regions in ambulatory patients; presacral area in bedridden patients);

Hepatomegaly and Splenomegaly: Painful hepatic enlargement due to venous congestion, positive hepatojugular reflux, and ascites;

Gastrointestinal Congestion: Anorexia, nausea, abdominal bloating, and early satiety.

Medical and Nursing Management of Heart Failure

Hemodynamic & Weight Monitoring: Daily weights taken at the same time each morning using the same scale, after voiding and before breakfast. A weight gain of > 1 to 2 kg (2 to 3 lbs) in 24 hours or > 2.5 kg (5 lbs) in one week indicates acute fluid retention and warrants urgent diuretic adjustment;

Dietary Restrictions: Sodium restriction (< 2 g elemental sodium per day) to minimize fluid retention; fluid restriction (1.5 to 2.0 L/day) in advanced or hyponatremic heart failure;

Loop Diuretics (Furosemide): Potent intravenous or oral diuretic inhibiting the Na-K-2Cl cotransporter in the thick ascending limb of Henle. Promotes rapid diuresis and preload reduction. Nursing focus: Monitor for hypokalemia , hyponatremia, dehydration, hypotension, and ototoxicity (with rapid IV boluses);

ACE Inhibitors (e.g., Lisinopril) & ARBs: Reduce afterload via arterial vasodilation and block aldosterone-mediated remodeling. Monitor for hyperkalemia, acute kidney injury, dry cough, and angioedema;

Beta-Blockers (e.g., Carvedilol, Bisoprolol, Metoprolol succinate): Inhibit sympathetic overdrive and reverse cardiac remodeling. Must be introduced slowly in clinically euvolemic, stable patients; never initiate or up-titrate during acute decompensated cardiogenic shock ;

Digoxin Monitoring & Toxicity Protocols:

Positive inotropic, negative chronotropic cardiac glycoside that improves cardiac contractility while slowing AV nodal conduction;

Therapeutic Serum Concentration: 0.5 to 2.0 ng/mL (narrow therapeutic index);

Nursing Administration Rule: Always auscultate the apical pulse for a full 60 seconds prior to administration; hold the dose and notify the physician if the apical pulse is < 60 beats per minute in an adult (or < 90 bpm in an infant);

Manifestations of Digitalis Toxicity:

  • Gastrointestinal: Anorexia (earliest sign), nausea, vomiting, diarrhea;
  • Neurological: Fatigue, confusion, headache, drowsiness;

Visual Disturbances: Blurred vision, photophobia, and characteristic yellow-green halos (xanthopsia) around objects or lights;

Cardiac: Sinus bradycardia, premature ventricular contractions (bigeminy), AV block, and life-threatening ventricular tachycardia.

Electrolyte Alert: Hypokalemia (< 3.5 mmol/L) dramatically heightens myocardial sensitivity to digoxin, precipitating fatal toxicity even at normal therapeutic serum digoxin concentrations. Hypomagnesemia and hypercalcemia also enhance toxicity.

Classifications of Shock

Shock is a life-threatening, generalized state of systemic hypoperfusion characterized by the failure of the circulatory system to deliver sufficient oxygenated blood to satisfy cellular metabolic requirements, resulting in cellular dysoxia, anaerobic metabolism, and lactic acidosis. +---------------------------------------------------------------------------------+

  • | FOUR PRIMARY TYPES OF SHOCK |
  • +---------------------------------------------------------------------------------+
  • | 1. HYPOVOLEMIC: Absolute loss of intravascular circulating blood or fluid |
  • | volume (e.g., hemorrhagic trauma, burns, severe cholera). |
  • | |
  • | 2. CARDIOGENIC: Primary mechanical pump failure of the myocardium with |
  • | inadequate cardiac output despite adequate volume (e.g., MI). |
  • | |
  • | 3. DISTRIBUTIVE: Profound systemic vasodilation and capillary leak resulting |
  • | in severe relative hypovolemia (Septic, Anaphylactic, |
  • | Neurogenic). |
  • | |
  • | 4. OBSTRUCTIVE: Physical mechanical impediment to ventricular filling or |
  • | cardiac outflow (Tamponade, Tension Pneumothorax, Massive PE). |
  • +---------------------------------------------------------------------------------+
  • Clinical and Hemodynamic Profiles

Hypovolemic Shock: Characterized by low central venous pressure (CVP), low pulmonary capillary wedge pressure (PCWP), low cardiac output (CO), and compensatory high systemic vascular resistance (SVR). Patients are tachycardic, tachypneic, with cool, pale, clammy extremities, delayed capillary refill (> 3 seconds), and oliguria (< 0.5 mL/kg/h);

Cardiogenic Shock: Characterized by elevated filling pressures (high CVP and PCWP), severely depressed cardiac output (cardiac index < 2.2 L/min/m2), and high SVR. Manifests with hypotension, pulmonary crackles, S3 gallop, and cold extremities;

Distributive Shock Subtypes:

Septic Shock: Dysregulated host response to infection with refractory hypotension requiring vasopressors to maintain a Mean Arterial Pressure (MAP) >= 65 mmHg and serum lactate > 2 mmol/L despite adequate fluid resuscitation (30 mL/kg crystalloid). Early ("warm") phase exhibits hyperdynamic high CO and low SVR (warm, flushed skin); late ("cold") phase features myocardial depression and peripheral vasoconstriction;

Anaphylactic Shock: Severe IgE-mediated type I hypersensitivity reaction causing massive mast cell degranulation. Massive histamine release triggers systemic vasodilation, profound capillary permeability, laryngeal edema, and severe bronchospasm. Immediate first-line drug: Intramuscular Epinephrine (Adrenaline) 1:1,000 (0.3 to 0.5 mg) injected into the anterolateral mid-thigh;

Neurogenic Shock: Results from acute spinal cord injury at or above T6, disrupting sympathetic outflow. Hallmark clinical triad: Hypotension, Bradycardia, and Warm, Dry Skin (due to complete loss of vasomotor tone and unopposed parasympathetic vagal stimulation);

Obstructive Shock: Caused by extrinsic compression:

Cardiac Tamponade: Beck's triad (hypotension, jugular venous distention, muffled heart sounds) and pulsus paradoxus;

Tension Pneumothorax: Severe respiratory distress, unilateral absent breath sounds, tracheal deviation to the contralateral side;

Massive Pulmonary Embolism: Acute RV strain, severe hypoxemia, acute cor pulmonale.

Pathophysiological Stages of Shock

Initial Stage: Cellular hypoperfusion without overt clinical symptoms; metabolic transition from aerobic to anaerobic metabolism produces lactic acid;

Compensatory Stage: Neural, hormonal, and chemical compensatory mechanisms are activated (sympathetic stimulation, RAAS activation, ADH release) to maintain cerebral and coronary perfusion. Manifests as tachycardia, tachypnea, peripheral vasoconstriction (pale, cool skin), normal or mildly decreased systolic blood pressure, and decreased urine output;

Progressive Stage: Compensatory mechanisms fail. Tissue perfusion becomes profoundly compromised; capillary permeability leads to widespread interstitial edema; mean arterial pressure falls < 60 mmHg; profound lactic acidosis, oliguria, somnolence, and dysrhythmias develop;

Irreversible (Refractory) Stage: Profound cellular destruction, severe metabolic acidosis, and microvascular thrombosis lead to Multiple Organ Dysfunction Syndrome (MODS). The patient is unresponsive to fluids, inotropes, and vasopressors; clinical demise is inevitable.

Resuscitation Priorities

Airway & Ventilation: Secure a patent airway; deliver high-flow supplemental oxygen or initiate mechanical ventilation to decrease oxygen consumption;

Intravascular Volume Expansion: Rapid infusion of isotonic crystalloids (0.9% Normal Saline or Ringer's Lactate) at 30 mL/kg within the first 3 hours for hypovolemic and septic shock. Boluses must be given with extreme caution in cardiogenic shock;

Vasoactive Drug Support: When fluid resuscitation fails to restore MAP >= 65 mmHg:

  • Norepinephrine (Levophed): First-line potent alpha-1 adrenergic vasopressor in septic and distributive shock;
  • Dobutamine: First-line inotropic agent for cardiogenic shock to augment myocardial contractility;

Epinephrine: Mandatory in anaphylaxis and refractory shock.